List view / Grid view
17 April 2019 | By European Pharmaceutical Review
An influenza vaccine manufacturer has announced it is filing an Annual Strain Update with the US Food and Drug Administration (FDA) in the coming weeks due to advances in influenza vaccine technology.
18 January 2019 | By Almac Group
The Almac Group, a CDMO serving the pharmaceutical and biotech sectors globally, is expanding its Edinburgh Technopole facility to allow scale-up of its personalised cancer vaccine activities...
14 January 2019 | By Nikki Withers (European Pharmaceutical Review)
Chinese police say they have opened an investigation into reports that at least 145 children received an expired polio vaccine...
22 May 2018 | By European Pharmaceutical Review
Nanoparticles could offer a new way to help eradicate the disease worldwide...
2 May 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
New research could serve as the stepping-stone in constructing vaccines with a greater likelihood of finding and attacking...
13 April 2018 | By European Pharmaceutical Review
Researchers aim to develop a new immunotherapy that could alter the immune reactions to food. The result: Extended relief from peanut allergies...
12 April 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Engineers have developed a miniature, ultra-low power injectable biosensor that could be used for continuous, long-term alcohol monitoring...
4 April 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Researchers have used kappa-carrageenan and nanosilicates to form injectable hydrogels to promote haemostasis and facilitate wound healing...
27 March 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Novel vaccine technologies are critical to improving the public health response to infectious disease threats that continually emerge and re-emerge, according to scientists at the NIAID...
13 March 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Medical researchers point to a promising route for designing an effective vaccine for the respiratory syncytial virus...
1 March 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
NIAID officials detail the Institute’s new strategic plan for addressing the research areas essential to creating a safe and effective universal influenza vaccine...
19 February 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Study is the first 'prevention of infection' trial conducted for tuberculosis, the world's leading infectious disease killer...
13 February 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
New injectable delivery system can slowly release drug carriers for months...
6 February 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Technical advances in vaccine production should shorten the time to clinical trials, breaking the logjam of promising new candidate vaccines waiting to be tested...
7 December 2017 | By European Pharmaceutical Review
Results from two Phase 1 clinical trials show an experimental Zika vaccine is safe and induces an immune response in healthy adults.
Follow: